PodParley PodParley
PodParley
ESMO19 - KEYNOTE-522: vaker pathologische complete respons bij toevoeging pembrolizumab aan neoadjuvante chemotherapie. In gesprek met Peter Schmid. episode artwork

EPISODE · Oct 5, 2019 · 9 MIN

ESMO19 - KEYNOTE-522: vaker pathologische complete respons bij toevoeging pembrolizumab aan neoadjuvante chemotherapie. In gesprek met Peter Schmid.

from Oncologie.nu

Episode metadata supplied by the publisher feed · Published Oct 5, 2019

Embed this episode

Ready to play

ESMO19 - KEYNOTE-522: vaker pathologische complete respons bij toevoeging pembrolizumab aan neoadjuvante chemotherapie. In gesprek met Peter Schmid.

0:00 9:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncologie.nu?

This episode is 9 minutes long.

When was this Oncologie.nu episode published?

This episode was published on October 5, 2019.

Can I download this Oncologie.nu episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!